|
| (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one Basic information |
Product Name: | (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one | Synonyms: | (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one;(112)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one;Aromatic A-ring Ulipristal Acetate;(8S,9R,11S,13S,14S,17R)-17-Acetyl-11-(4-(dimethylamino)phenyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl Acetate;19-Norpregna-1,3,5(10)-trien-20-one, 17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-, (11β)- | CAS: | 709615-25-8 | MF: | C30H37NO4 | MW: | 475.61908 | EINECS: | | Product Categories: | Pharmaceuticals, Intermediates & Fine Chemicals, Steroids | Mol File: | 709615-25-8.mol | |
| (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one Chemical Properties |
Boiling point | 612.8±55.0 °C(Predicted) | density | 1.21±0.1 g/cm3(Predicted) | pka | 10.22±0.70(Predicted) |
| (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one Usage And Synthesis |
Uses | (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one is a antiprogestational/antiglucocorticoid agent and a progestin and glucocorticord receptor antagonist. |
| (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one Preparation Products And Raw materials |
|